Robert J Hondal

12PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesEnvironmental biogeochemistryHealth and ecological risk assessmentFish pests and diseasesTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 31, 2025
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy.

Kimberly J Nelson, Terrence L Smalley, Terri Messier

|Dec 14, 2022
What Is the Redox Potential of Ergothioneine?

Robert J Hondal

|Feb 25, 2022
Oxidized Forms of Ergothioneine Are Substrates for Mammalian Thioredoxin Reductase.

Kaelyn A Jenny, Gracyn Mose, Daniel J Haupt

|Nov 09, 2021
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits Karenia brevis and Mammalian Thioredoxin Reductases by Targeting Different Residues.

Ricardo Colon, Michelle Wheater, Emily J Joyce

|May 19, 2021
Ergothioneine in a peptide: Substitution of histidine with 2-thiohistidine in bioactive peptides.

Kaelyn A Jenny, Erik L Ruggles, Matthew D Liptak

|Oct 27, 2020
Aggregation State of Synergistic Antimicrobial Peptides.

Jacob M Remington, Chenyi Liao, Mona Sharafi

Pageof 2

Frequent Collaborators

1 joint publications

Severin T Schneebeli

1 joint publications

Jianing Li

1 joint publications

Kathleen S Rein

1 joint publications

Kaelyn A Jenny